Tech Company Financing Transactions
Aspen Neuroscience Funding Round
Aspen Neuroscience, based in San Diego, received $40 million from Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
12/24/2022
Transaction Type
Debt
Amount
$40,000,000
Round
Undisclosed
Investors
Silicon Valley Bank (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate growth and expand operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Aspen is developing enabling technologies for patient-specific induced pluripotent stem cell-based therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Howard Federoff
Chief Financial Officer
Jay Sial
Chief Medical Officer
Edward Wirth
Chief Scientific Officer
Jeanne Loring
VP - Bus. Development
Naveen Krishnan
VP - Manufacturing
Thorsten Gorba
VP - R & D
Andres Bratt-Leal
Browse more venture capital transactions:
Prev: 12/24/2022: Razor venture capital transaction
Next: 12/25/2022: Lipogems venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs